{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-125299","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2025-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.805067+00:00","generated_at":"2026-05-16T12:13:28.737208+00:00","sec_items":["1.01","3.02"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"China Pharma subsidiary acquires Ipragliflozin patent for $9.8M in stock","bullets":["Hainan Helpson enters Technology Transfer Agreement to acquire Ipragliflozin tablet patent from Juan Zhang.","Total consideration: $9.8 million paid in 7,000,000 restricted CPHI shares at $1.40 per share.","Transferor to provide technical services including product R&D, registration materials, and application.","Shares issued under Regulation S to non-U.S. person, unregistered and exempt from Securities Act registration."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-125299","json":"https://secwatch.observer/filing/0001213900-25-125299.json","markdown":"https://secwatch.observer/filing/0001213900-25-125299.md","text":"https://secwatch.observer/filing/0001213900-25-125299.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000121390025125299/0001213900-25-125299-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000121390025125299/ea0270909-8k_chinapharm.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:13:28.737208+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}